BARCLAYS PLC - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 190 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$385
-81.5%
113,404
-60.0%
0.00%
-100.0%
Q2 2023$2,083
+28.0%
283,407
+80.5%
0.00%0.0%
Q1 2023$1,627
-42.2%
157,021
-34.1%
0.00%0.0%
Q4 2022$2,816
-99.9%
238,415
+40.1%
0.00%
-75.0%
Q3 2022$3,571,000
+393.2%
170,190
+629.4%
0.00%
Q2 2022$724,000
-72.7%
23,333
-63.9%
0.00%
-100.0%
Q1 2022$2,650,000
-52.3%
64,555
-49.5%
0.00%
+100.0%
Q4 2021$5,552,000
+136.7%
127,742
+172.7%
0.00%0.0%
Q3 2021$2,346,000
-15.4%
46,845
+6.4%
0.00%0.0%
Q2 2021$2,774,000
-43.4%
44,028
-16.5%
0.00%
-66.7%
Q1 2021$4,902,000
+32.9%
52,753
+28.1%
0.00%
+50.0%
Q4 2020$3,689,000
-47.2%
41,177
-39.1%
0.00%
-50.0%
Q3 2020$6,991,000
+23.6%
67,662
-5.4%
0.00%0.0%
Q2 2020$5,656,000
-23.5%
71,519
-44.0%
0.00%
-33.3%
Q1 2020$7,394,000
-26.0%
127,791
-31.0%
0.01%0.0%
Q4 2019$9,995,000
+235.6%
185,259
+225.2%
0.01%
+200.0%
Q3 2019$2,978,000
-2.6%
56,960
-10.0%
0.00%0.0%
Q2 2019$3,058,000
+51.0%
63,298
+57.9%
0.00%
+100.0%
Q1 2019$2,025,000
+28.2%
40,097
+50.6%
0.00%0.0%
Q4 2018$1,579,000
-48.5%
26,623
-42.8%
0.00%
-50.0%
Q3 2018$3,067,000
+346.4%
46,582
+242.3%
0.00%
+100.0%
Q2 2018$687,000
-48.0%
13,609
-45.7%
0.00%0.0%
Q1 2018$1,320,000
+26.4%
25,077
+11.7%
0.00%0.0%
Q4 2017$1,044,000
+90.5%
22,456
+65.7%
0.00%0.0%
Q3 2017$548,000
-21.9%
13,556
-34.6%
0.00%0.0%
Q2 2017$702,000
+1797.3%
20,725
+1544.8%
0.00%
Q1 2017$37,000
-77.2%
1,260
-74.5%
0.00%
Q4 2016$162,000
+60.4%
4,936
+54.9%
0.00%
Q3 2016$101,000
+74.1%
3,187
+55.7%
0.00%
Q2 2016$58,000
-92.3%
2,047
-90.2%
0.00%
-100.0%
Q1 2016$749,000
+10600.0%
20,798
+13232.1%
0.00%
Q4 2015$7,000
-92.0%
156
-95.0%
0.00%
Q3 2015$87,000
-77.9%
3,114
-74.7%
0.00%
Q2 2015$393,000
+1210.0%
12,307
+1038.5%
0.00%
Q1 2015$30,000
-46.4%
1,081
-47.6%
0.00%
Q4 2014$56,000
+166.7%
2,063
+100.7%
0.00%
Q3 2014$21,000
-97.5%
1,028
-97.3%
0.00%
-100.0%
Q2 2014$827,000
-58.3%
37,596
-52.6%
0.00%
-50.0%
Q1 2014$1,985,000
+2105.6%
79,396
+1814.5%
0.00%
Q4 2013$90,000
-73.4%
4,147
-76.7%
0.00%
Q3 2013$338,000
+17.8%
17,796
-10.5%
0.00%
Q2 2013$287,00019,8760.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders